No products in the cart.
21 people are viewing this product right now
🔥 6 items sold in last 3 hours
Gonadorelin Acetate is a synthetic version of gonadotropin-releasing hormone (GnRH), which is responsible for regulating the release of gonadotropins—luteinizing hormone (LH) and follicle-stimulating hormone (FSH)—from the anterior pituitary gland. It is used therapeutically to treat various reproductive and hormonal disorders, including infertility, polycystic ovary syndrome (PCOS), and delayed puberty. Gonadorelin Acetate works by stimulating the hypothalamic-pituitary-gonadal (HPG) axis, promoting the natural release of gonadotropins.
【pictures linking,https://pubchem.ncbi.nlm.nih.gov/compound/638793】
Sequence: Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
Molecular Formula:C55H75N17O13·C2H4O2
Molecular Weight:1182.3 g/mol
PubChem CID: 638793
CAS Number:34973-08-5
Synonyms: Growth Hormone Releasing Factor, Somatocrinin, Somatoliberin
Gonadorelin Acetate is a synthetic form of gonadotropin-releasing hormone (GnRH), a decapeptide that stimulates the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These downstream hormones regulate the hypothalamic-pituitary-gonadal (HPG) axis, making Gonadorelin a foundational peptide in fertility medicine, hormone restoration, and endocrine diagnostics.
It is bioidentical to natural human GnRH and is commonly used for diagnostic testing, hypogonadism treatment, and even puberty induction.
Binds to GnRH receptors on anterior pituitary gonadotrophs, triggering a pulsatile release of LH and FSH, which in turn stimulate testosterone, estradiol, and spermatogenesis or folliculogenesis depending on sex.
In pulsed dosing, Gonadorelin mimics natural hypothalamic function.
In continuous high-dose exposure, it desensitizes GnRH receptors, reducing LH/FSH—useful in hormone-sensitive cancers.
Used to evaluate pituitary reserve and delayed puberty in adolescents (NIH Protocol).
Approved for hypogonadotropic hypogonadism and secondary amenorrhea in both sexes.
Enhances testosterone and sperm production in subfertile men with low LH levels 【https://pubmed.ncbi.nlm.nih.gov/3104967/】.
Journal of Clinical Endocrinology & Metabolism: “Gonadorelin remains the gold standard for assessing GnRH responsiveness in suspected pituitary or hypothalamic dysfunction.”
Reproductive endocrinologists note its “predictable pharmacokinetics, short half-life, and excellent pituitary selectivity” as major clinical advantages.
🧬 Directly stimulates natural LH/FSH production
💡 Ideal for diagnosis or reversal of HPG axis suppression
💪 Supports testosterone production and fertility in men
🩺 Beneficial in female reproductive restoration, PCOS or amenorrhea
🚫 Alternative to exogenous hormone therapy, lowers side effects risk
🧠 Non-immunogenic, short-acting, and highly predictable
Gonadorelin is being increasingly used in post-anabolic steroid recovery protocols to re-initiate natural LH/FSH/testosterone axis function.
May replace hCG, which can desensitize Leydig cells with long-term use.
Combined use with Clomiphene or Enclomiphene under investigation for full axis restoration.
Future studies are exploring microdose pulsatile delivery via programmable infusion pumps to mimic natural GnRH rhythm for treating:
Anovulatory infertility
PCOS-related ovulatory dysfunction
Functional hypothalamic amenorrhea (FHA)
Could offer more physiological results than exogenous LH/FSH injections.
High-dose Gonadorelin is being evaluated as an alternative to GnRH agonists (like Leuprolide) for prostate and breast cancer, with faster reversibility and less bone density loss.
Promising option in GnRH antagonist-sensitive tumors, offering shorter receptor desensitization window and lower cardiovascular risks.
Intranasal and sublingual spray formulations under development to replace IV/subQ delivery while preserving pulsatility.
Biochip or wearable infusion devices being tested for fertility patients.
Used to test HPG axis integrity in:
Delayed puberty
Hypogonadism
Amenorrhea
→ GnRH stimulation test – NIH【https://www.ncbi.nlm.nih.gov/books/NBK538254/】
Men: Improves LH → testosterone → sperm production
Women: Re-establishes FSH/LH → ovulation → estradiol normalization
→ GnRH in fertility – Reproductive Biology Update
【https://pubmed.ncbi.nlm.nih.gov/21890336/】
Used by clinicians and longevity doctors to restart testosterone production following anabolic steroid use.
High-dose protocols under trial for:
Prostate cancer
Endometrial or breast cancer
With faster hormonal recovery than traditional agonists
→ Gonadorelin vs GnRH agonists
【https://pubmed.ncbi.nlm.nih.gov/21111083/】
Infusion pump use in infertility clinics to replicate circadian GnRH pulsatility and improve ovulation rates without hyperstimulation
Gonadorelin Acetate is a potent, precise, and flexible regulator of reproductive hormones:
✔️ Directly activates natural LH and FSH release
✔️ Used in diagnostics, fertility, post-steroid recovery, and cancer therapy
✔️ Offers reversible, short-acting hormone control
✔️ Highly adaptable via infusion pumps, injections, or future nasal delivery
✔️ Validated across pediatrics, reproductive medicine, and oncology
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies(Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
$33.60
$33.60
Reviews
There are no reviews yet.